These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2270755)

  • 1. Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis.
    Askmark H; Aquilonius SM; Gillberg PG; Hartvig P; Hilton-Brown P; Lindström B; Nilsson D; Stålberg E; Winkler T
    Acta Neurol Scand; 1990 Oct; 82(4):253-8. PubMed ID: 2270755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.
    Hartvig P; Askmark H; Aquilonius SM; Wiklund L; Lindström B
    Eur J Clin Pharmacol; 1990; 38(3):259-63. PubMed ID: 2340845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tetrahydroaminoacridine: relations to clinical and biochemical effects in Alzheimer patients.
    Ahlin A; Adem A; Junthé T; Ohman G; Nybäck H
    Int Clin Psychopharmacol; 1992; 7(1):29-36. PubMed ID: 1624754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year on tacrine (THA): clinical and biochemical effects in patients with dementia of the Alzheimer type.
    Ahlin A; Junthé T; Hassan M; Nybäck H
    Int Psychogeriatr; 1995; 7(1):75-83. PubMed ID: 7579023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot trial of dextromethorphan in amyotrophic lateral sclerosis.
    Askmark H; Aquilonius SM; Gillberg PG; Liedholm LJ; Stålberg E; Wuopio R
    J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):197-200. PubMed ID: 8437010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.
    Ibebunjo C; Donati F; Fox GS; Eshelby D; Tchervenkov JI
    Anesth Analg; 1997 Aug; 85(2):431-6. PubMed ID: 9249126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrine in Alzheimer's disease: pharmacokinetic and clinical comparison of oral and rectal administration.
    Ahlin A; Hassan M; Junthé T; Nybäck H
    Int Clin Psychopharmacol; 1994; 9(4):263-70. PubMed ID: 7868848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
    Wilcock GK; Surmon DJ; Scott M; Boyle M; Mulligan K; Neubauer KA; O'Neill D; Royston VH
    Age Ageing; 1993 Sep; 22(5):316-24. PubMed ID: 8237620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and effects of 9-amino-1,2,3,4-tetrahydroacridine in the immediate postoperative period in neurosurgical patients.
    Hartvig P; Pettersson E; Wiklund L; Lindström B
    J Clin Anesth; 1991; 3(2):137-42. PubMed ID: 2039641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
    Forsyth DR; Wilcock GK; Morgan RA; Truman CA; Ford JM; Roberts CJ
    Clin Pharmacol Ther; 1989 Dec; 46(6):634-41. PubMed ID: 2598567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tolerance of 7-methoxytacrine following the single dose administration in healthy volunteers.
    Filip V; Vachek J; Albrecht V; Dvorák I; Dvoráková J; Fusek J; Havlůj J
    Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):431-6. PubMed ID: 1800389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tetrahydroaminoacridine on sleep in healthy subjects.
    Riemann D; Lis S; Fritsch-Montero R; Meier T; Krieger S; Hohagen F; Berger M
    Biol Psychiatry; 1996 May; 39(9):796-802. PubMed ID: 8731520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.
    Bruno R; Vivier N; Montay G; Le Liboux A; Powe LK; Delumeau JC; Rhodes GR
    Clin Pharmacol Ther; 1997 Nov; 62(5):518-26. PubMed ID: 9390108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemals, a new drug candidate, extends lifespan and improves electromyographic parameters in a rat model of amyotrophic lateral sclerosis.
    Nicaise C; Coupier J; Dabadie MP; De Decker R; Mangas A; Bodet D; Poncelet L; Geffard M; Pochet R
    Amyotroph Lateral Scler; 2008 Apr; 9(2):85-90. PubMed ID: 18428000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A follow-up electromyographic investigation of ALS patients treated with high dosage gangliosides.
    Pinelli P; Mazzini L; Mora G; Pisano F; Villani A
    Adv Exp Med Biol; 1987; 209():285-91. PubMed ID: 3577919
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.
    Joerger M; Wilkins J; Fagagnini S; Baldinger R; Brenneisen R; Schneider U; Goldman B; Weber M
    Drug Metab Lett; 2012 Jun; 6(2):102-8. PubMed ID: 22594565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis.
    Cudkowicz ME; Sexton PM; Ellis T; Hayden DL; Gwilt PR; Whalen J; Brown RH
    Neurology; 1999 Apr; 52(7):1492-4. PubMed ID: 10227642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.